Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123021172 | 12302117 | 2 | F | 2016 | 20160725 | 20160425 | 20160728 | PER | US-CELGENEUS-USA-2016045838 | CELGENE | 0.00 | F | Y | 0.00000 | 20160728 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123021172 | 12302117 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | U | B0013AE,B2005AA | 20785 | 50 | MG | CAPSULES | QD | ||||
| 123021172 | 12302117 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | U | B0013AE,B2005AA | 20785 | 100 | MG | CAPSULES | QD | ||||
| 123021172 | 12302117 | 3 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123021172 | 12302117 | 4 | C | Codeine | CODEINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123021172 | 12302117 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123021172 | 12302117 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123021172 | 12302117 | 7 | C | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123021172 | 12302117 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123021172 | 12302117 | 9 | C | Donepezil hcl | DONEPEZIL HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123021172 | 12302117 | 1 | Plasma cell myeloma |
| 123021172 | 12302117 | 3 | Product used for unknown indication |
| 123021172 | 12302117 | 4 | Product used for unknown indication |
| 123021172 | 12302117 | 5 | Product used for unknown indication |
| 123021172 | 12302117 | 6 | Product used for unknown indication |
| 123021172 | 12302117 | 7 | Product used for unknown indication |
| 123021172 | 12302117 | 8 | Product used for unknown indication |
| 123021172 | 12302117 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123021172 | 12302117 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123021172 | 12302117 | Amnesia | |
| 123021172 | 12302117 | Cerebrovascular accident | |
| 123021172 | 12302117 | Fatigue | |
| 123021172 | 12302117 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123021172 | 12302117 | 1 | 201603 | 0 | ||
| 123021172 | 12302117 | 2 | 201603 | 0 |